Head-to-Head

Kymera Therapeutics, Inc. Common Stock vs. Sutro Biopharma, Inc.

KYMR

Kymera Therapeutics, Inc. Common Stock

$119.72 -4.87%

VS STRO

Sutro Biopharma, Inc.

$8.92 -4.29%

Kymera Therapeutics, Inc. Common Stock and Sutro Biopharma, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

KYMRSTRO
Market Cap $10.74 billion $154.73 million

KYMR leads on 1 of 1 size & scale factors.

Risk & Sentiment

KYMRSTRO
Short Interest 0.23% 0.07%

STRO leads on 1 of 1 risk & sentiment factors.

Dig deeper: KYMR overview, KYMR financials, STRO overview, STRO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.